key: cord-0773885-2wnfl4pr
authors: Zhou, Jie; Otter, Jonathan A; Price, James R; Cimpeanu, Cristina; Garcia, Danel Meno; Kinross, James; Boshier, Piers R; Mason, Sam; Bolt, Frances; Holmes, Alison H; Barclay, Wendy S
title: Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London
date: 2020-07-08
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa905
sha: 89ca4ebd17d4d07bfab91b179db2e224ae4ef259
doc_id: 773885
cord_uid: 2wnfl4pr

BACKGROUND: Evaluation of SARS-CoV-2 surface and air contamination during the COVID-19 pandemic in London. METHODS: We performed this prospective cross-sectional observational study in a multi-site London hospital. Air and surface samples were collected from seven clinical areas, occupied by patients with COVID-19, and a public area of the hospital. Three or four 1.0 m(3) air samples were collected in each area using an active air sampler. Surface samples were collected by swabbing items in the immediate vicinity of each air sample. SARS-CoV-2 was detected by RT-qPCR and viral culture; the limit of detection for culturing SARS-CoV-2 from surfaces was determined. RESULTS: Viral RNA was detected on 114/218 (52.3%) of surfaces and 14/31 (38.7%) air samples but no virus was cultured. The proportion of surface samples contaminated with viral RNA varied by item sampled and by clinical area. Viral RNA was detected on surfaces and in air in public areas of the hospital but was more likely to be found in areas immediately occupied by COVID-19 patients than in other areas (67/105 (63.8%) vs. 29/64 (45.3%) (odds ratio 0.5, 95% confidence interval 0.2-0.9, p=0.025, Chi squared test)). The high PCR Ct value for all samples (>30) indicated that the virus would not be culturable. CONCLUSIONS: Our findings of extensive viral RNA contamination of surfaces and air across a range of acute healthcare settings in the absence of cultured virus underlines the potential risk from environmental contamination in managing COVID-19, and the need for effective use of PPE, physical distancing, and hand/surface hygiene.

The severe acute respiratory syndrome coronavirus (SARS-CoV-2) virus has rapidly spread around the world since it emerged in late 2019, resulting in a coronavirus disease 2019 (COVID- 19) pandemic. [1] Evidence from SARS, influenza, and SARS-CoV-2 suggests droplet and contact spread as primary transmission routes with evidence of airborne spread during aerosol generating procedures (AGPs). [1, 2] Hospital-onset COVID-19 infection (HOCI) has been reported, and is probably linked to ineffective implementation of infection prevention and control measures. [1, [3] [4] [5] The transmission dynamics in healthcare environments are unclear and likely to be multifactorial. Contaminated surfaces and air were a key part of the transmission dynamics of SARS, MERS, influenza, and other organisms in hospitals. [1, 2, 6] Laboratory evidence suggests that the SARS-CoV-2 virus can survive on dry surfaces and in aerosols for days to weeks, particularly on non-porous surfaces. [7, 8] Furthermore, SARS-CoV-2 RNA has been detected on surfaces and in the air in hospitals that are caring for patients with COVID-19. [9] [10] [11] [12] [13] [14] [15] [16] [17] However, our understanding of the role of surface and air contamination in the transmission of SARS-CoV-2 is limited. Most studies to date have relied on PCR, and have not attempted to culture virus thereby limiting the ability to interpret PCR-based detection; have focussed upon one geographical region (Asia); and have included a limited selection of clinical and non-clinical areas with no evidence from operating theatre environments. [9, 10, 12, 13, 15, 16] In mid-April 2020, the UK experienced the first wave of the COVID-19 pandemic. During this period, there was evidence for HOCI. [5] Therefore, to inform and optimise infection prevention and control interventions, we evaluated SARS-CoV-2 surface and air contamination across a range of clinically-relevant locations (including operating theatres) and public areas during the peak of the COVID-19 pandemic in A c c e p t e d M a n u s c r i p t London, using both RT-PCR and viral culture. We also performed supporting laboratory experiments to assess SARS-CoV-2 viability on surfaces, with associated limits of detection, to qualify our findings.

Sample collection for this prospective cross-sectional study was performed between April 2 nd and 20 th 2020 on selected wards at a large North West London teaching hospital group comprising five hospitals across four sites with 1,200 acute beds. Most sampling was conducted on one hospital site during the peak of the COVID-19 pandemic (Supplemental Figure 1 ) when most patients were managed in cohort wards.

Seven clinical areas (emergency department, an admissions ward, two COVID-19 cohort wards, theatres during tracheostomy procedures, an admissions ward, an intensive care unit, and a 6bedded bay converted into a negative pressure area for management of continuous positive airway pressure (CPAP) on patients with COVID-19) and a public area of the hospital were selected to represent the diversity of clinical environments (Supplemental Table 1 ).

All inpatient wards were fully occupied by adult patients with COVID-19 at the time of sampling, apart from the Emergency Department. In the part of the Emergency Department dedicated for patients with confirmed or suspected COVID-19, two of the cubicles were occupied and one patient was in the ambulatory wait area at the time of sampling.

All areas were disinfected daily with an additional twice daily disinfection of high touch surfaces using a combined chlorine-based detergent/disinfectant (Actichlor Plus, Ecolab). M a n u s c r i p t

In each clinical area, between three and five air samples were collected. High touch surfaces in the immediate vicinity of each air sample were sampled, including bed rails, clinical monitoring devices (blood pressure monitors), ward telephones, computer keyboards, clinical equipment (syringe pumps, urinary catheters), hand-cleaning facilities (hand washing basins, alcohol gel dispensers). In each clinical area, sampling was performed in both patient (i.e. bays and single rooms) and nonpatient care areas (i.e. nursing stations and staff rooms). Environmental sampling was conducted during three tracheostomy procedures. During the first procedure, air sampling was performed before and during the procedure; for the other procedures, air sampling was performed during the procedure only. 

Viral RNA detection and absolute quantification was performed using quantitative real-time reverse transcription polymerase chain reaction (RT-qPCR). Samples were extracted from 140 µL of the DMEM medium using the QIAamp viral RNA mini kit (Qiagen, Germany). Negative controls (water) were extracted and included in the PCR assays. SARS-CoV-2 viral RNA was detected using AgPath-ID One-Step RT-PCR Reagents (Life Technologies) with specific primers and probes targeting the envelope (E) gene. [18] A standard curve with six serial dilutions of 1x10 5 -1 x 10 0 copies/µL E gene was included in each RT-qPCR run. E gene copies per m 3 air and copies per swab were calculated. Viral culture: Vero E6 (African Green monkey kidney) and Caco2 (human colon carcinoma) cells were used to culture virus from air and environmental samples using a method adapted from one previously used to culture influenza virus. [19] The cells were maintained in DMEM supplemented with heat inactivated fetal bovine serum (10%) and Penicillin/Streptomycin (10, 000 IU/mL &10, 000 µg/mL). For virus isolation, 200 µL of samples were added to 24 well plates. On day 0 and after 5-7 days, cell supernatants were collected, and RT-qPCR to detect SARS-CoV-2 performed as described above. Samples with at least one log increase in copy numbers for the E gene (reduced Ct values relative to the original samples) after 5-7 days propagation in cells compared with the starting value were considered positive by viral culture.

We performed a laboratory experiment to determine the limit of detection for culturing SARS-CoV-2 dried on surfaces. A log 10 dilution series from solution containing 8.25x10 6 PFU/mL SARS-CoV-2 (titred by plaque assay in Vero cells) from 10 -3 to 10 -6 (covering Ct values from 26 to 36 and E gene copies from 10 6 to 10 3 ) was produced in DMEM and 50 µL of each dilution was inoculated in triplicate onto the surface of plastic (standard keyboard key) or stainless steel (2 x 1 x 0.2 cm) pieces.

The inoculated surfaces were dried in a safety cabinet for 2 hours after which they were visibly dry.

They were then sampled using flocked swabs. Swabs were deposited into 1.5 mL of DMEM for 1 hour, and then 100 µL used to inoculate wells of VeroE6 cells culture in 24 well plates. RT-qPCR was used to determine viability following 7 days of culture as follows. 140 µL was used for RNA extraction and qPCR immediately (0 days post inoculation, dpi) and after incubation for 7 days in a 24-well plate with VeroE6 cells (7 dpi). Samples with an increase in copy numbers for the E gene 

A Chi square test was used to compare the proportion of environmental samples (surfaces or air) that were positive or suspected for SARS-CoV-2 RNA in areas immediately occupied by patients with COVID-19 with other areas. The mean concentration of air and surface contamination in each of the areas was log transformed and then compared by one-way ANOVA followed by Tukey's multiple comparisons test.

The work was registered locally as an NHS service evaluation (#434).

114/218 (52.3%) of surface samples were suspected (91/218 (41.7%)) or positive (23/218 (10.6%)) for SARS-CoV-2 RNA but no virus was cultured ( Table 1 ). The proportion of surface samples with suspected or positive RNA varied by item, including >80% of computer keyboards/mice, alcohol gel dispensers, and chairs, and >50% of toilet seats, sink taps, and patient bedrails ( Figure 1 ). 14/31 (38.7%) of air samples were suspected (12/31 (38.7%)) or positive 92/31 (6.4%)) for SARS-CoV-2 RNA but no virus was cultured (Table 1) . 10 1 to 10 3 genome copies / m 3 of SARS-CoV-2 RNA was detected in air from all eight areas tested (Table 1) ; there was no significant difference in mean viral RNA concentration across the eight areas tested (p=0.826). Similarly, 10 1 to 10 4 genome copies per swab SARS-CoV-2 RNA was detected in surface samples from all eight areas tested ( Figure 2 ). There was a significant difference in the mean SARS-CoV-2 surface viral load across the eight areas tested Since viable virus was not cultured from any of the air or surface samples, we performed laboratory experiments to determine the limit of detection of SARS-CoV-2 dried onto surfaces. Four different dilutions of virus deposited onto two non-porous surfaces determined that dried inocula with a Ct value <30 (corresponding to an E gene copy number of ≥10 5 per mL) yielded SARS-CoV-2 that could be cultured ( A c c e p t e d M a n u s c r i p t

We did not identify viable virus on any surface or air sample. Few studies have attempted to culture SAR-CoV-2 from healthcare environments, and no viable virus was detected. [11, 15] Our laboratory study of the viability of virus dried on surfaces helps to qualify our findings and the findings of others, suggesting that Ct values of >30 corresponding to an E gene copy number of <10 5 per mL are unlikely to be culturable (Table 2) . This finding parallels studies of viral infectivity from clinical specimens. [21, 22] Bearing in mind that the viral RNA detected in the hospital setting might have been deposited more than two hours previously, we cannot differentiate whether our inability to culture virus from the samples is explained by the low RNA levels or the length of time since deposition which may reflect non-viable viral RNA. It is also possible that virus was infectious but not culturable in the laboratory.

Surface contamination was detected on a range of items, especially computer keyboards, chairs, and alcohol dispensers. Other studies have also identified computer keyboards and/or mice as a risk for SARS-CoV-2 RNA contamination. [9, 10, 12] Many of the computers that we sampled were in shared staff clinical areas (such as nursing stations), so this argues for frequent disinfection of these items.

The contamination of alcohol gel dispensers is unsurprising since staff hands activate these before hand hygiene is performed. However, alcohol gel dispensers should be included in routine cleaning and disinfection protocols or designed such that they can be activated without touching.

We sampled several areas where AGPs are commonly performed There was no difference in the viral load of the air across the eight areas sampled, suggesting that AGPs do not produce persistently high levels of air contamination. However, we did not sample the air over time, and our air sampling method did not differentiate particle size so we are unable to distinguish droplets from aerosols (< 5 µM). One recent study identified SARS-CoV-2 RNA at low levels (in the 10 1 -10 2 range copies per m 3 ) in patient care areas in a permanent and field hospital in Wuhan, China. [14] Positive samples were identified in a range of particle sizes, including those <5 µM, which would typically be considered as A c c e p t e d M a n u s c r i p t aerosols. [2] It seems likely, therefore, that the positive and suspected air samples identified in our study included a range of particle sizes spanning 5 µM, particularly in areas where aerosol generating procedures are common.

Whilst we sampled in a temporary CPAP ward, no patient was undergoing CPAP at the time of sampling. However, one patient was undergoing HFNC during sampling, and air contamination was identified <1 m from this patient. A recent summary of evidence concludes that HFNC is a lower risk procedure in terms of aerosol generation than CPAP, which should be a topic for future studies. [23] We identified surface and air contamination during three tracheostomy procedures. Several studies and commentaries have evaluated the potential for surgical procedures to produce aerosols for patients with COVID-19.[24-26] One study evaluated the spread of droplets during tracheostomies, although did not include sampling for SARS-CoV-2.

[24] Our findings highlight a potential theoretical risk of COVID-19 transmission during these procedures. However, a larger sample size is required to understand this risk.

Strengths of our study includes our sampling strategy encompassing contemporaneous surface and air samples from a range of patient and non-patient care areas with diversity in physical layout and ventilation and including operating theatres and areas dedicated to known and potential AGPs; each sample was tested using PCR and viral culture, and we performed laboratory experiments to quality our findings; the sampling was conducted during the peak of the pandemic (and so likely represents a worst-case scenario). Limitations include not collecting patient samples to better understand how our findings links to patient samples, particularly during tracheostomies and AGPs; no asymptomatic patient or staff testing at the time of sampling, which means asymptomatic patients and staff could have shed SARS-CoV-2; challenges in interpreting the significance of samples with low viral loads; a A c c e p t e d M a n u s c r i p t lack of resolution of particle sizes for contamination of the air; and as no longitudinal sampling was performed these findings represent a "snapshot". 

Can we contain the COVID-19 outbreak with the same measures as for SARS? The Lancet Infectious diseases

Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination

Temporal dynamics in viral shedding and transmissibility of COVID-19

The impact of testing and infection prevention and control strategies on within-hospital transmission dynamics of COVID-19 in English hospitals

Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. The New England journal of medicine

Stability of SARS-CoV-2 in different environmental conditions

Environmental contamination by SARS-CoV-2 in a designated hospital for coronavirus disease 2019

Environmental contamination of SARS-CoV-2 in healthcare premises

SARS-CoV-2 RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus Disease 2019 outbreak in a Chinese hospital

Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards

Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient

Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

SARS-CoV-2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit. Clinical microbiology and infection : the official publication of the

Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients

Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro surveillance : bulletin Europeen sur les maladies transmissibles

Isolation of H5N6, H7N9 and H9N2 avian influenza A viruses from air sampled at live poultry markets in China

Culture-based virus isolation to evaluate potential infectivity of clinical specimens tested for COVID-19

SARS-CoV-2 shedding and infectivity

Clinical evidence based review and recommendations of aerosol generating medical procedures in otolaryngologyhead and neck surgery during the COVID-19 pandemic

Overview of guidance for endoscopy during the coronavirus disease 2019 pandemic

Facial protection for healthcare workers during pandemics: a scoping review

Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal

Endoscopic Skull Base and Transoral Surgery During the COVID-19 Pandemic: Minimizing Droplet Spread with a Negative-Pressure Otolaryngology Viral Isolation Drape (NOVID)

We wish to acknowledge the staff teams and patients who supported this sampling during the peak of the challenges posed by this pandemic. 

M a n u s c r i p t contamination in managing COVID-19, and the need for effective use of PPE, physical distancing, and hand/surface hygiene.A c c e p t e d M a n u s c r i p t

All authors met the ICMJE criteria for authorship. JZ and JAO conceived the study, collected and analysed data, and wrote the manuscript; JRP conceived the study, collected data, and contributed to the manuscript; CP, DMG, PRB, SM collected data and contributed to the manuscript; FB, AHH, and WSB conceived the study, analysed data, and contributed to the manuscript. JAO is the study guarantor.

All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: JAO reports personal fees from Gama Healthcare Ltd and Pfizer in the past three years